Citation: | ZANG Peng, LI Jinxia, LI Ji, ZHANG Huizhi, GU Yan. Experimental study of Huangqi Guizhi Wuwu Decoctionin prevention and treatment of rats model with deep venous thrombosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 12-17. DOI: 10.7619/jcmp.20220385 |
To investigate the mechanism of Huangqi Guizhi Wuwu Decoction in prevention and treatment of rats model with deep venous thrombosis (DVT).
A total of 40 male SD rats with specific pathogen free (SPF) grade were randomly divided into sham operation group,model group,Chinese medicine group and heparin calcium group,with 10 rats in each group. Except for the sham operation group,the femoral vein thrombosis models of rats with incomplete ligation were established in the other three groups. In the Chinese medicine group,2.0 g/(kg·d) of freeze-dried powder solution of Huangqi Guizhi Wuwu Decoction was given by intragastric administration; in the heparin calcium group,351.43 IU/(kg·d) of low molecular weight heparin calcium was given by subcutaneous injection; in the sham operation group and the model group,distilled water was given by intragastric administration; the administration time for rats in each group was from 7 days before modeling to 7 days after modeling,once a day,lasting for 14 days. After treatment,the abdominal aorta blood of rats in each group was collected to detect the coagulation indicators such as activated partial thromboplastin time (APTT),prothrombin time (PT),thrombin time (TT),fibrinogen (FIB) and D-dimer (D-D),and the plasma metabolites were analyzed; the femoral vein segments of rats in each group were collected to observe the histomorphological differences of venous thrombosis segments.
Compared with the sham operation group,the levels of FIB and D-D in the model group increased significantly,and APTT,PT and TT shortened significantly (P < 0.05); compared with the model group,the FIB and D-D levels decreased significantly in the heparin calcium group and the Chinese medicine group,while APTT,PT and TT prolonged significantly (P < 0.05); compared with the heparin calcium group,the level of D-D in the Chinese medicine group was significantly lower (P < 0.05). Plasma metabolic analysis showed that there were 27 differential metabolites between the model group and the sham operation group; Huangqi Guizhi Wuwu Decoction could significantly restore 14 differential metabolites,involving the improvement of vitamin K,trimethylamine N-oxide (TMAO),anserine,L-carnosine,carnitine metabolism,bile acid metabolism and lipid metabolism; low molecular weight heparin could significantly restore 8 differential metabolites,involving TMAO,anserine,L-carnosine,carnitine metabolism and amino acid metabolism. Histomorphological results showed that there was no thrombosis in the venous lumen in the sham operation group; in the model group,the venous lumen was filled with thrombus,and the inflammatory cell infiltration was more serious; in the heparin calcium group,part of the thrombus in the venous lumen disintegrated,part of the thrombus contracted,and the inflammatory cell infiltration was lighter than that in the model group; in the Chinese medicine group,most of the thrombus in the venous lumen disintegrated and disappeared,a small amount of thrombus remained and contracted,and the inflammatory cell infiltration in the vascular wall was light,which indicated the degree of pathological damage was light.
Huangqi Guizhi Wuwu Decoction has the effects of anticoagulation,improving metabolic disorder,inhibiting thrombosis,protecting vascular endothelial cells and reducing inflammatory cell infiltration,which may be the important mechanism for treatment of DVT.
[1] |
KOSKINAS P,INTAS G,STERGIANNIS P,et al. Incidence of deep vein thrombosis and its effect on health-related quality of life among nurses of Greek public hospitals:a multicenter study[J].Adv Exp Med Biol,2021,1337:37-45.
|
[2] |
COHEN A T,AGNELLI G,ANDERSON F A,et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality[J].Thromb Haemost,2007,98(4).756-764.
|
[3] |
ARSHAD N,BJORI E,HINDBERG K,et al. Recurrence and mortality after first venous thromboembolism in a large population-based cohort[J].J Thromb Haemost,2017,15(2).295-303. doi: 10.1111/jth.13587
|
[4] |
HEIT J A,SPENCER F A,WHITE R H. The epidemiology of venous thromboembolism[J].J Thromb Thrombolysis,2016,41(1).3-14. doi: 10.1007/s11239-015-1311-6
|
[5] |
孙聪,王钧,常永梅. 国内深静脉血栓流行病学特征和危险因素研究进展[J].齐齐哈尔医学院学报,2015,36(15).2282-2283. https://www.cnki.com.cn/Article/CJFDTOTAL-QQHB201515058.htm
|
[6] |
马晓婷,柴秀英,沈辛酉,等. 上海、西宁地区下肢深静脉血栓病人临床流行病学特征分析[J].护理研究,2016,30(1).113-115. doi: 10.3969/j.issn.1009-6493.2016.01.038
|
[7] |
戴璐璐. 深静脉血栓形成住院患者生活质量现状及影响因素分析[D].武汉:武汉轻工大学,2021.
|
[8] |
于洋,王景,张海丽. 中医药治疗下肢深静脉血栓研究进展[J].辽宁中医药大学学报,2019,21(2).137-140. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201902039.htm
|
[9] |
赵志丽,赵远红,陈茂艳,等. 赵远红运用黄芪桂枝五物汤辨治肺癌下肢静脉栓塞症验案1则[J].上海中医药杂志,2018,52(12).29-30. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201812009.htm
|
[10] |
戴越保. 黄芪桂枝五物汤预防膝关节置换术后深静脉血栓的临床研究[D].合肥:安徽中医药大学,2014.
|
[11] |
张朝顺,柯常江,冯起校,等. 建立更符合临床的深静脉血栓形成大鼠模型的研究[J].新医学,2014,45(10).647-651. doi: 10.3969/g.issn.0253-9802.2014.10.004
|
[12] |
SMITH C A,WANT E J,O'MAILLE G,et al. XCMS:processing mass spectrometry data for metabolite profiling using nonlinear peak alignment,matching,and identification[J].Anal Chem,2006,78(3).779-787. doi: 10.1021/ac051437y
|
[13] |
张福先,王深明. 静脉血栓栓塞症诊断与治疗[M].北京:人民卫生出版社,2013:73-73.
|
[14] |
杨鹏,强晓军,苏海涛,等. 利伐沙班与低分子肝素预防脊柱骨折手术后下肢深静脉血栓的效果及不良反应比较[J].中国药物滥用防治杂志,2021,27(4).528-531. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYLF202104024.htm
|
[15] |
胡天洋,蒋幼凡. 新型口服抗凝药治疗静脉血栓栓塞症的效果及安全性的Meta分析[J].河北医科大学学报,2019,40(3).286-291. doi: 10.3969/j.issn.1007-3205.2019.03.009
|
[16] |
杨晓娜,赵良虎,黄金,等. 依诺肝素钠与磺达肝癸钠预防膝关节置换术后深静脉血栓的对比研究[J].中国医院用药评价与分析,2021,21(10).1176-1179. https://www.cnki.com.cn/Article/CJFDTOTAL-YYPF202110006.htm
|
[17] |
RAJ K,CHANDNA S,DOUKAS S G,et al. Combined use of wells scores and D-dimer levels for the diagnosis of deep vein thrombosis and pulmonary embolism in COVID-19:a retrospective cohort study[J].Cureus,2021,13(9).e17687.
|
[18] |
SKYE S M,ZHU W F,ROMANO K A,et al. Microbial transplantation with human gut commensals containing CutC is sufficient to transmit enhanced platelet reactivity and thrombosis potential[J].Circ Res,2018,123(10).1164-1176. doi: 10.1161/CIRCRESAHA.118.313142
|
1. |
蒋志达,张斌. 通督健脑针法联合固本宣肺方辅助治疗急性脑卒中相关性肺炎疗效观察. 山西中医. 2022(01): 38-41 .
![]() | |
2. |
任向利,任向杰,马雪静,刘肇玮,白玉. 血清血红蛋白清道夫受体可溶性CD163联合中性粒细胞与淋巴细胞比值预测卒中相关性肺炎患者预后的价值. 实用临床医药杂志. 2022(02): 18-22 .
![]() | |
3. |
蒋和平,王劢,吴国荣,王丽东. 血清缺氧诱导因子-1α、肾上腺髓质素前体、甘胆酸水平与老年慢性阻塞性肺疾病急性加重期患者肺功能损伤进展的相关性. 实用临床医药杂志. 2022(05): 122-126 .
![]() | |
4. |
许江飞,周海燕,王宽红. 急性缺血性脑卒中相关性肺炎患者耐药性分析. 河南医学高等专科学校学报. 2022(02): 135-139 .
![]() | |
5. |
张莹,张倩春,姜瑜. 血清pro-ADM、pro-AVP/CPP动态监测评估ICU重症社区获得性肺炎患者预后价值分析. 实验与检验医学. 2020(06): 1153-1158 .
![]() |